NASDAQ:INMD InMode (INMD) Stock Price, News & Analysis → The Small Biotech with a BIG Cancer Solution (From Behind the Markets) (Ad) Free INMD Stock Alerts $21.20 +0.53 (+2.56%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$20.82▼$21.3450-Day Range$20.45▼$26.4952-Week Range$18.57▼$48.25Volume821,200 shsAverage Volume1.57 million shsMarket Capitalization$1.78 billionP/E Ratio9.22Dividend YieldN/APrice Target$33.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestSocial Media Get InMode alerts: Email Address InMode MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside55.7% Upside$33.00 Price TargetShort InterestBearish7.25% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.05Based on 10 Articles This WeekInsider TradingN/AProj. Earnings Growth6.70%From $2.24 to $2.39 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.94 out of 5 starsMedical Sector616th out of 939 stocksElectromedical Equipment Industry8th out of 18 stocks 3.2 Analyst's Opinion Consensus RatingInMode has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $33.00, InMode has a forecasted upside of 55.7% from its current price of $21.20.Amount of Analyst CoverageInMode has only been the subject of 2 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.25% of the outstanding shares of InMode have been sold short.Short Interest Ratio / Days to CoverInMode has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in InMode has recently increased by 5.91%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInMode does not currently pay a dividend.Dividend GrowthInMode does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INMD. Previous Next 1.7 News and Social Media Coverage News SentimentInMode has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for InMode this week, compared to 6 articles on an average week.Search InterestOnly 21 people have searched for INMD on MarketBeat in the last 30 days. This is a decrease of -19% compared to the previous 30 days.MarketBeat FollowsOnly 9 people have added InMode to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InMode insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.92% of the stock of InMode is held by insiders.Percentage Held by Institutions68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for InMode are expected to grow by 6.70% in the coming year, from $2.24 to $2.39 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InMode is 9.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.56.Price to Earnings Ratio vs. SectorThe P/E ratio of InMode is 9.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 255.57.Price to Book Value per Share RatioInMode has a P/B Ratio of 3.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About InMode Stock (NASDAQ:INMD)InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.Read More INMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INMD Stock News HeadlinesMarch 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd.- INMDMarch 27, 2024 | prnewswire.comContact Levi & Korsinsky by April 15, 2024 Deadline to Join Class Action Against InMode Ltd. (INMD)March 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 26, 2024 | seekingalpha.comInMode Does Not Look Pretty Right Now: Time To BuyMarch 26, 2024 | prnewswire.comContact The Gross Law Firm by April 15, 2024 Deadline to Join Class Action Against InMode Ltd.(INMD)March 23, 2024 | prnewswire.comROSEN, A LEADING NATIONAL FIRM, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMDMarch 22, 2024 | prnewswire.comINMD Investors Have Opportunity to Lead InMode Ltd. Securities Fraud LawsuitMarch 21, 2024 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InModeMarch 28, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 20, 2024 | prnewswire.comINMD LAWSUIT ALERT: Levi & Korsinsky Notifies InMode Ltd. Investors of a Class Action Lawsuit and Upcoming DeadlineMarch 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd.- INMDMarch 16, 2024 | prnewswire.comROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMDMarch 16, 2024 | ca.finance.yahoo.comINMD Apr 2024 32.000 callMarch 16, 2024 | finance.yahoo.comINMD Apr 2024 23.000 putMarch 15, 2024 | finance.yahoo.comINMD Apr 2024 18.000 callMarch 15, 2024 | msn.comInMode’s (NASDAQ:INMD) Recent Slid Makes it a Potential Gem for Long-Term Value InvestorsMarch 15, 2024 | prnewswire.comINMD Investors Have Opportunity to Lead InMode Ltd. Securities Fraud LawsuitMarch 15, 2024 | prnewswire.comClass Action Filed Against InMode Ltd. (INMD) - April 15, 2024 Deadline to Join - Contact Levi & KorsinskyMarch 14, 2024 | stockhouse.comINMD SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds InMode Ltd. Investors to Join the Class Action Lawsuit!March 14, 2024 | prnewswire.comInvestors in InMode Ltd. Should Contact The Gross Law Firm Before April 15, 2024 to Discuss Your Rights - INMDMarch 13, 2024 | stockhouse.comINMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds InMode Ltd. Investors to Join the Class Action Lawsuit!March 13, 2024 | markets.businessinsider.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of InModeMarch 12, 2024 | ca.style.yahoo.comSKIMS Stands the Test of Time in Its First-Ever TV CommercialMarch 12, 2024 | insidermonkey.comShould You Hold InMode Ltd. (INMD)?March 12, 2024 | prnewswire.comInMode Ltd. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2024 to Discuss Your Rights - INMDMarch 11, 2024 | stockhouse.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd. - INMDMarch 11, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against InMode Ltd.- INMDSee More Headlines Receive INMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/13/2024Today3/27/2024Next Earnings (Estimated)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:INMD CUSIPN/A CIK885988 Webwww.inmodemd.com Phone972-4909-7470FaxN/AEmployees581Year Founded2008Price Target and Rating Average Stock Price Target$33.00 High Stock Price Target$61.00 Low Stock Price Target$22.00 Potential Upside/Downside+55.7%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$2.30 Trailing P/E Ratio9.22 Forward P/E Ratio9.46 P/E GrowthN/ANet Income$197.92 million Net Margins40.22% Pretax Margin44.30% Return on Equity29.80% Return on Assets27.02% Debt Debt-to-Equity RatioN/A Current Ratio12.51 Quick Ratio11.87 Sales & Book Value Annual Sales$492.05 million Price / Sales3.62 Cash Flow$2.29 per share Price / Cash Flow9.25 Book Value$6.68 per share Price / Book3.17Miscellaneous Outstanding Shares83,980,000Free Float78,170,000Market Cap$1.78 billion OptionableOptionable Beta2.17 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Yair Malca (Age 46)Chief Financial Officer Comp: $581kMs. Nava Tal-LaunerChief Information OfficerMr. Shakil Lakhani (Age 41)President of North America Comp: $3.49MMr. Moshe Mizrahy (Age 71)Chairman & CEO Comp: $216kMr. Alon YaariVice President of OperationsDr. Michael Kreindel (Age 56)CTO & Director Comp: $221kDr. Spero Theodorou M.D. (Age 52)Chief Medical Officer Comp: $1.84MMore ExecutivesKey CompetitorsNatus MedicalNASDAQ:NTUSCONMEDNYSE:CNMDTransMedics GroupNASDAQ:TMDXBioLife SolutionsNASDAQ:BLFSLivaNovaNASDAQ:LIVNView All CompetitorsInstitutional OwnershipVanguard Group Inc.Sold 141,854 shares on 3/11/2024Ownership: 0.890%Trust Co. of VermontBought 536 shares on 3/8/2024Ownership: 0.003%Virtu Financial LLCBought 1,465 shares on 2/26/2024Ownership: 0.036%Price T Rowe Associates Inc. MDBought 1,650 shares on 2/16/2024Ownership: 0.057%Price T Rowe Associates Inc. MDBought 1,650 shares on 2/15/2024Ownership: 0.058%View All Institutional Transactions INMD Stock Analysis - Frequently Asked Questions Should I buy or sell InMode stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" INMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INMD, but not buy additional shares or sell existing shares. View INMD analyst ratings or view top-rated stocks. What is InMode's stock price target for 2024? 5 equities research analysts have issued 1-year price targets for InMode's shares. Their INMD share price targets range from $22.00 to $61.00. On average, they expect the company's stock price to reach $33.00 in the next year. This suggests a possible upside of 55.7% from the stock's current price. View analysts price targets for INMD or view top-rated stocks among Wall Street analysts. How have INMD shares performed in 2024? InMode's stock was trading at $22.24 at the beginning of 2024. Since then, INMD stock has decreased by 4.7% and is now trading at $21.20. View the best growth stocks for 2024 here. Are investors shorting InMode? InMode saw a increase in short interest in March. As of March 15th, there was short interest totaling 6,090,000 shares, an increase of 5.9% from the February 29th total of 5,750,000 shares. Based on an average trading volume of 1,540,000 shares, the short-interest ratio is presently 4.0 days. View InMode's Short Interest. When is InMode's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our INMD earnings forecast. How were InMode's earnings last quarter? InMode Ltd. (NASDAQ:INMD) announced its earnings results on Tuesday, February, 13th. The healthcare company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.05. The healthcare company earned $126.80 million during the quarter, compared to the consensus estimate of $124.77 million. InMode had a trailing twelve-month return on equity of 29.80% and a net margin of 40.22%. The business's revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.69 earnings per share. What ETFs hold InMode's stock? ETFs with the largest weight of InMode (NASDAQ:INMD) stock in their portfolio include The Acquirers Fund (ZIG), Amplify BlueStar Israel Technology ETF (ITEQ), ARK Israel Innovative Technology ETF (IZRL), VanEck Israel ETF (ISRA) and iShares MSCI Israel ETF (EIS).Vident International Equity Strategy ETF (VIDI). When did InMode's stock split? InMode's stock split on the morning of Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly created shares were issued to shareholders after the closing bell on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What guidance has InMode issued on next quarter's earnings? InMode issued an update on its FY24 earnings guidance on Tuesday, February, 13th. The company provided earnings per share guidance of $2.53-2.57 for the period, compared to the consensus EPS estimate of $2.46. The company issued revenue guidance of $495-505 million, compared to the consensus revenue estimate of $499.20 million. What is Moshe Mizrahy's approval rating as InMode's CEO? 1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of InMode own? Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL). When did InMode IPO? InMode (INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager. Who are InMode's major shareholders? InMode's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Meitav Investment House Ltd. (2.34%), LSV Asset Management (2.34%), Boston Trust Walden Corp (1.75%), DDD Partners LLC (1.48%), Nuveen Asset Management LLC (1.16%) and Migdal Insurance & Financial Holdings Ltd. (1.08%). How do I buy shares of InMode? Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does InMode have any subsidiaries? The following companies are subsidiares of InMode: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..Read More This page (NASDAQ:INMD) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.